“…We observed no difference in AMCase protein levels in BAL fluid between controls and patients with ILD or asthma (Figure 7B and Figure S7B). AMCase activity can vary with common gene polymorphisms (Seibold et al, 2009; Aminuddin et al, 2012; Okawa et al, 2016), but no differences in exo-or endochitinase activity were observed in BAL fluid between controls and patients with ILD; however, notably, human endochitinase activity in all but one patient sample was comparatively lower than in mouse BAL fluid, and in contrast to normal β-N-acetylglucosaminidase activity (Figure 7C), supporting prior studies describing relatively inefficient enzymatic activity among common human AMCase isoforms (Seibold et al, 2009; Goedken et al, 2011; Okawa et al, 2016). Further, as assessed using CBD-reactive material, significantly increased amounts of chitin polymers were present in BAL fluid from patients with ILD as compared to healthy controls (Figure 7D).…”